Featured Research

from universities, journals, and other organizations

McMaster Researchers Develop Test For Rare Bleeding Disorder

Date:
January 13, 2005
Source:
McMaster University, Faculty Of Health Sciences
Summary:
Researchers at McMaster University have developed the first assessment tool of its kind for evaluating risks faced by Canadians suffering from a rare and often fatal bleeding disorder.

Hamilton, ON (Dec. 21, 2004) -- Researchers at McMaster University have developed the first assessment tool of its kind for evaluating risks faced by Canadians suffering from a rare and often fatal bleeding disorder.

Related Articles


Their detailed bleeding questionnaire helps discriminate between patients - often in the same family - affected by a puzzling and rare condition known as Quebec Platelet Disorder (QPD) and those who are not.

The new tool for detecting different symptoms and complications was developed in the laboratory of hematologist Dr. Catherine Hayward, an associate professor in the departments of pathology and molecular medicine and medicine in the Michael G. DeGroote School of Medicine of McMaster's Faculty of Health Sciences. The Transfusion Medicine Research Team at McMaster, headed by Nancy Heddle, helped develop the tool. Before Hayward began her research, Quebec families with this bleeding disorder didn't know what was causing their illness--or even what they suffered from.

Bleeding disorders tend to run in families and can be particularly difficult to detect. Normally, when a person bleeds, blood clots stop the bleeding. The clotting process (coagulation) requires both blood cells (platelets) and proteins (clotting factors). In bleeding disorders, blood platelets are not working as they should or there are too few platelets, or clotting factors, which cause bleeding to continue for longer than normal.

Gold standard tests are available to determine risks in diseases such as heart attacks and strokes but there has never been gold standards for rare bleeding disorders, such as QPD. Although this specific disorder appears to affect a few families in Quebec, this tool is a step forward to developing a better way to assess bleeding problems in many other conditions.

The McMaster researchers developed a detailed bleeding history questionnaire based on interviews with physicians and focus groups of patients who suffered a broad spectrum of bleeding disorders, and applied this with a "gold standard" laboratory test her group developed for the QPD.

"It is touching that what patients told us to ask about proved to be valuable clues to helpful bleeding symptoms," said Dr. Hayward.

The researchers gave the questionnaire to 127 relatives in two families with QPD who ranged in age from one year to 89 years. Their average age was 34.

They found those with QPD had a much higher likelihood of bleeding that led to lifestyle changes, bruises that spread or became as large, or larger, than an orange, bleeding in joints and bleeding that lasted longer than 24 hours. The study has established the consequences of inheriting the QPD - a disease that transforms platelets from "clot formers" into "clot busters."

"This is going to be very helpful to doctors trying to sort out if a patient with bleeding has the QPD," said Dr. Hayward.

Dr. James N. George of the University of Oklahoma Health Sciences Centre commented in the journal Blood that the study by McMaster scientists has important lessons for hematologists who investigate and manage patients with bleeding disorders by providing new insights into this condition.

"The use of quantitative measures of bleeding symptoms will allow for greater understanding of the interactions of multiple common inherited traits on the risks for excessive bleeding," he said.

Fifteen years ago, Dr. Hayward made scientific history when she discovered a previously unknown protein called multimerin 1, one of the largest proteins in the human body. This discovery led her to study bleeding problems experienced by QPD families and how platelets support blood clotting.

Earlier this month, Samira B. Jeimy, a graduate student in Hayward's McMaster research laboratory, presented a study that was chosen from among more than 5,700 abstracts submissions for delivery at the American Society of Hematology's annual meeting in San Diego. The society's annual meeting is the premier hematology meeting in the world and attended by more than 20,000 scientists.

Jeimy's study centred on the molecular interactions between the platelet protein multimerin 1 and the blood clot accelerator factor V. She found that factor V and multimerin 1 bind in a unique way, without blocking clot formation. Ultimately, the advance may lead to new tests and treatments for diseases with too little, or too much, blood clot formation, such as heart attacks and strokes.

Jeimy is enrolled in the medical sciences graduate program at McMaster and holds a master's studentship award from the Heart and Stroke Foundation of Ontario. Her research was supported by a Canadian Institutes of Health Research (CIHR) grant, and by Dr. Hayward's Heart and Stroke Foundation Career Investigator Award and Canada Research Chair. The study was done in collaboration with world experts on factor V - Dr. William Kane, Duke University, United States; Dr. Bjorn Dahlback, Lund University, Sweden; and Dr. Gerry Nicolaes, Maastricht University, Netherlands.


Story Source:

The above story is based on materials provided by McMaster University, Faculty Of Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

McMaster University, Faculty Of Health Sciences. "McMaster Researchers Develop Test For Rare Bleeding Disorder." ScienceDaily. ScienceDaily, 13 January 2005. <www.sciencedaily.com/releases/2005/01/050111180448.htm>.
McMaster University, Faculty Of Health Sciences. (2005, January 13). McMaster Researchers Develop Test For Rare Bleeding Disorder. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2005/01/050111180448.htm
McMaster University, Faculty Of Health Sciences. "McMaster Researchers Develop Test For Rare Bleeding Disorder." ScienceDaily. www.sciencedaily.com/releases/2005/01/050111180448.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins